Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02590640 · ClinicalTrials.gov registry record · NA
Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02590640 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 40 participants.
The verdict
NCT02590640, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this study is to determine if a specific experimental brain stimulation technique can be used as a non-invasive way to reduce cigarette cravings in current smokers. This study plans to learn more about the way an experimental technique called "transcranial magnetic stimulation" (TMS) affects a specific part of the brain, called the insula. Some research suggests that this part of the brain plays an important role in craving. The investigators plan to study the effects of TMS using standard surveys and magnetic resonance imaging (MRI) of subjects' brain. For interested participants, this study requires a single 3 hour appointment, which will include MRI of the brain as well as TMS.
Interventions
- DEVICE Sham repetitive transcranial magnetic stimulation
- DEVICE Repetitive transcranial magnetic stimulation, MagStim Rapid2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-11 |
| Est. Completion | 2019-09-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02590640
The ClinicalTrials.gov registry entry for NCT02590640 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham repetitive transcranial magnetic stimulation is the first listed.
NCT02590640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02590640 about?
NCT02590640 is a clinical study titled "Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers". The goal of this study is to determine if a specific experimental brain stimulation technique can be used as a non-invasive way to reduce cigarette cravings in current smokers. This study plans to learn more about the way an experimental technique called "transcranial magnetic stimulation" (TMS) aff...
What is the current status of trial NCT02590640?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-11. Estimated completion is 2019-09-06.
What interventions are being tested in trial NCT02590640?
The interventions under investigation include: Sham repetitive transcranial magnetic stimulation (DEVICE), Repetitive transcranial magnetic stimulation, MagStim Rapid2 (DEVICE).
Who is sponsoring clinical trial NCT02590640?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.